Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032761 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Juri Na und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Symporters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Improved therapeutic strategies are required to minimize side effects associated with radioiodine gene therapy to avoid unnecessary damage to normal cells and radiation-induced secondary malignancies. We previously reported that codon-optimized sodium iodide symporter (oNIS) enhances absorption of I-131 and that the brahma-associated gene 1 bromodomain (BRG1-BRD) causes inefficient DNA damage repair after high-energy X-ray therapy. To increase the therapeutic effect without applying excessive radiation, we considered the combination of oNIS and BRG1-BRD as gene therapy for the most effective radioiodine treatment. The antitumor effect of I-131 with oNIS or oNIS+BRD expression was examined by tumor xenograft models along with functional assays at the cellular level. The synergistic effect of both BRG1-BRD and oNIS gene overexpression resulted in more DNA double-strand breaks and led to reduced cell proliferation/survival rates after I-131 treatment, which was mediated by the p53/p21 pathway. We found increased p53, p21, and nucleophosmin 1 (NPM1) in oNIS- and BRD-expressing cells following I-131 treatment, even though the remaining levels of citrulline and protein arginine deiminase 4 (PAD4) were unchanged at the protein level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- Cancer Imaging Centre, Seoul National University Hospital, Seoul 03080, Republic of Korea.
ORCID-Profile: Juri Na, Chul-Hee Lee
Förderung
- National Research Foundation of Korea
Zitieren
APA
Na, J., Lee, C. H., Chung, J. K., & Youn, H. (2023). Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032761
Vancouver
Na J, Lee CH, Chung JK, Youn H. Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032761
BibTeX
@article{Na2023,
author = {Na, Juri and Lee, Chul-Hee and Chung, June-Key and Youn, Hyewon},
title = {Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032761}
}
EUVIMED